Health Condition 1: R52- Pain, unspecified Health Condition 2: null- sub-acute and chronic pain
Conditions
Interventions
Intervention1: CP-010: Homeopathy pills 30c potency for two weeks.
Dose- 6 pills three times daily.
Intervention2: Magnesium Phospharicum: Homeopathy pills 30c potency for two weeks. Dose- 6 pills thr
Sponsors
Homeopathy India Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: Patients with moderate to severe pain at baseline (NRS 4 - 10) (Indicating the intensity of pain.),Any Sub-acute and chronic painful condition.Patients who continue to have significant pain in spite of any form of pain killer medication. Such patients should be able to manage without increasing the dose of current pain-killers or changing to another pain-killer medicine, during the course of study. Patient has been informed about the study and has given her/his written informed consent.Patient understands the investigational nature of the extension study and is willing and willing to comply with trial protocol. Patients having any sub-acute or chronic pain.
Exclusion criteria
Exclusion criteria: Patients with severe pain due to critical conditions such as chronic abdominal conditions such as appendicitis, cholicytisis, pancreatitis, renal colic, acute rheumatoid arthritis, severe psoriatic arthritis, septic arthritis, etc.Pregnant and lactating women,Mentally retarded patients,Patients with severe or incapacitating baseline pain.Participation in a clinical trial with an investigational agent during the past 30 days or Simultaneous participation in a clinical study, Severe uncontrolled systemic disease such as diabetes, hypertension.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical trial to evaluate the efficacy of potentized preparation CP-010 30c potency by measuring the reduction in intensity of pain using Numeric rating scale (NRS)Timepoint: Efficacy end points weekly at week 1 and week 2. | — |
Secondary
| Measure | Time frame |
|---|---|
| Global Impression(CGI)scale10. Effect of pain on sleep. Number of patients report adverse reactions Need for Rescue Medication Change in Vital signs Laboratory evaluations Changes in symptoms. Time needed for the patient to be symptom free. Duration of period of relief Timepoint: Clinical- at 1 week and week 2, lab parameters after 2 weeks. | — |
Countries
India
Contacts
Public ContactDr Rajesh Shah
Life Force Center
Outcome results
None listed